Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hoi-ki Kate Lui"'
Efficacy and Tolerability of Brivaracetam in Chinese Population: Focus on Switch From Levetiracetam.
Autor:
Wui-hang Ryan Ho, Leung, C. Y. William, Chan, M. H. Holy, Sze-wai Yeung, Hoi-ki Kate Lui, Lui, H. T. Colin, Chan, L. Y. Eric, Lo, Cheuk-nam Rachel, Yu-hin Ian Leung, Hui Ning Florinda Chu, Chang, Shek-kwan Richard
Publikováno v:
American Journal of Therapeutics; Nov/Dec2023, Vol. 30 Issue 6, pe565-e570, 6p
Autor:
Wui-hang Ryan Ho, C. Y. William Leung, M. H. Holy Chan, Sze-wai Yeung, Hoi-ki Kate Lui, H. T. Colin Lui, L. Y. Eric Chan, Cheuk-nam Rachel Lo, Yu-hin Ian Leung, Hui Ning Florinda Chu, Shek-kwan Richard Chang
Publikováno v:
American journal of therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8384573de79764dfbf795eadac6657cd
https://pubmed.ncbi.nlm.nih.gov/35604724
https://pubmed.ncbi.nlm.nih.gov/35604724
Autor:
Ka Keung Yam, Yujie Wang, Hoi Ki Kate Lui, Richard Shek-kwan Chang, William C.Y. Leung, Yu Hin Ian Leung
Publikováno v:
Journal of the neurological sciences. 405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f71306bf8945c3603459fdd255282a
https://pubmed.ncbi.nlm.nih.gov/31445298
https://pubmed.ncbi.nlm.nih.gov/31445298
Publikováno v:
Seizure. 40:42-45
s Purpose To identify predictors of poor clinical outcome in patients presenting to the intensive care units with status epilepticus (SE), in particular for patients presenting with de novo status epileptics. Methods A retrospective review was perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3783af31a4dccf7b96c0a8ccedbb8b
https://doi.org/10.1016/j.seizure.2016.06.006
https://doi.org/10.1016/j.seizure.2016.06.006
Autor:
Yujie Olivia Wang, C.Y. William Leung, Richard Shek-kwan Chang, Hoi Ki Kate Lui, Yu Hin Ian Leung, Hiu Tung Colin Lui
Publikováno v:
Journal of the Neurological Sciences. 409:116601
Lacosamide (LCM) is a new generation antiepileptic drug. It has only been available in Asia in recent years. A retrospective study at two hospitals in Hong Kong was performed to investigate the post-marketing efficacy and tolerability of the drug. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b05e9a562d75b61af7c031112120c28a
https://doi.org/10.1016/j.jns.2019.116601
https://doi.org/10.1016/j.jns.2019.116601